Dr. Potter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
420 Delaware St. SE
MMC480
Minneapolis, MN 55455Phone+1 612-625-8933Fax+1 612-676-4005- Is this information wrong?
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1993
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1992
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1986 - 1988
Johns Hopkins University School of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1988 - Present
MN State Medical License 2006 - 2025
IN State Medical License 2000 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer Start of enrollment: 2010 May 26
Publications & Presentations
PubMed
- Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit-risk ratio of immuno-oncology therapy.Guo, Z., Lei, J., Potter, D., Antonarakis, E.> ;Proceedings of the National Academy of Sciences of the United States of America. 2024 Feb 27
- Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.Haiyun Wang, Douglas Yee, David Potter, Patricia Jewett, Christina Yau, Heather Beckwith, Allison Watson, Nicholas O'Grady, Amy Wilson, Susie Brain, Paula Pohlmann, , ...> ;Breast Cancer Research and Treatment. 2024 Apr 1
- 9 citationsLymphadenopathy after the third Covid-19 vaccine.Can Özütemiz, David Potter, Ayça Özbek Özütemiz, Daniel Steinberger> ;Current Problems in Cancer. Case Reports. 2021 Oct 30
- Join now to see all
Grant Support
- Potentiation of immune checkpoint blockade by inhibition of epoxyeicosatrienoic acid driven tumor respirationDOD2019–2022
- Epoxygenase Mechanisms Of Breast Cancer ProgressionNational Cancer Institute2007–2008
- Epoxygenease Mechanisms Of Breast Cancer ProgressionNational Cancer Institute2006
- Epoxygenase Mechanisms Of Breast Cancer ProgressionNational Cancer Institute2005
- Functional Analysis Of Transcription Factors In HIV-1National Cancer Institute1993–1996
- Functional Analysis Of Transcription Factors In HIV-1National Cancer Institute1991
- An Inducible Hepatic Polymerase II Transcription SystemNational Institute Of General Medical Sciences1985
Research History
- Associate ProfessorRoles of Cytochrome P450 Arachidonic Acid Oxidases in Breast Cancer Progression
Professional Memberships
- Member
- Member
Hospital Affiliations
M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
M Health Fairview Southdale HospitalMinneapolis, Minnesota
M Health Fairview Lakes Medical CenterWyoming, Minnesota
M Health Fairview Ridges HospitalBurnsville, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
